Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-13 @ 7:47 AM
Study NCT ID:
NCT01834651
Status:
COMPLETED
Last Update Posted:
2017-09-27
First Post:
2013-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases
Sponsor:
Edwin Posadas, MD
Organization: